fashion -WSS

fashion

author：leisure time 2025-08-26 23:44:48 - browse：8

Stock illustration of computer and medication — Adobe

Digital therapeutics company Click Therapeutics announced Wednesday it will acquire the assets of Better Therapeutics, developer of a software-based treatment for diabetes. Click, which did not disclose how much it is paying for the assets, hopes to adapt Better’s tech for use alongside GLP-1 medications.

Better Therapeutics announced in March that it was delisting from the Nasdaq stock exchange and shutting down operations as it sought strategic alternatives. The company had been, since last year, searching for ways to stay afloat as its cash reserves dwindled.

Last, year, Better received Food and Drug Administration clearance for AspyreRx, a prescription app that delivers cognitive behavioral therapy and had been shown to reduce A1c levels in people with type 2 diabetes. Still, the company has been unable to ramp up significant commercial traction. Better also had a pipeline of other products targeting cardiometabolic conditions, and had made early claims about the benefits of AspyreRx in people taking GLP-1s for diabetes management.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Dobbs anniversary: the lost opportunity of abortion as health care
Next article： Oak trusses raised to roof of fire

explore

WSS

Fauci’s Covid grilling leads GOP to weigh foreign research rules

Charles Manson follower Leslie Van Houten released from prison after 53 years

Doudna institute plans to 'cure hundreds of diseases' with CRISPR

New menopause drug shows promise in relief for hot flashes

Biden launches a new push to limit health care costs

Caregivers of transplant patients call for more support, training

leisure time

fashion

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

hotspot

Drug repurposing or repositioning? The language matters

FDA’s Peter Marks seems inclined to back Sarepta’s gene therapy

Supreme Court strikes down use of affirmative action

Generative AI mines health records to identify patients’ social needs

Jerome Adams on the need for new antivirals for Covid

Lecanemab for Alzheimer's is coming. Is the health system ready?

At least 13 dead in Texas as scorching temps continue

Caregivers of transplant patients call for more support, training

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Charles Manson follower Leslie Van Houten released from prison after 53 years

Wikipedia

Palantir health business leans on meeting customers’ needs

Biden launches a new push to limit health care costs

A new study sees potential in DNA sequencing of infants

It's time to get medical device identifiers over the finish line

Bulgari apologizes to China for listing Taiwan as a country after online backlash

Readout LOUD podcast: 2023 in review, and a look at biotech in 2024

knowledge

explore

explore

entertainment